HELLS: A Drug Target / Disease Biomarker (G3070)
HELLS: A Drug Target / Disease Biomarker
Hellps, also known as heat-inducing protein 2 (HIP-2), is a protein that has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.
Hellps is a cytoplasmic protein that is expressed in a variety of tissues, including the brain, pancreas, and heart. It is characterized by its ability to induce heat in cells, which can lead to cellular stress and damage. This protein has also been shown to play a role in the regulation of cell growth, apoptosis, and inflammation.
One of the reasons why Hellps has caught the attention of researchers is its potential as a drug target. Hellps has been shown to be involved in a variety of cellular processes that are associated with the development and progression of disease. For example, studies have shown that Hellps is involved in the regulation of cell adhesion, which is critical for the development of cancer stem cells. Additionally, Hellps has been shown to be involved in the regulation of cell apoptosis, which is important for the elimination of damaged or dysfunctional cells.
Another potential application of Hellps as a drug target is its role in the regulation of inflammation. Hellps has been shown to play a role in the regulation of inflammatory responses, and has been shown to be involved in the regulation of the production of pro-inflammatory cytokines. This suggests that Hellps may be a potential target for treatments aimed at reducing inflammation.
In addition to its potential as a drug target, Hellps has also been shown to be a potential biomarker for a variety of diseases. For example, studies have shown that Hellps is downregulated in a variety of cancer tissues, and may be a potential biomarker for the development of cancer. Additionally, Hellps has been shown to be involved in the regulation of insulin sensitivity, which is important for the development and progression of type 2 diabetes.
Overall, Hellps is a protein that has the potential to be a drug target and biomarker for a variety of diseases. Further research is needed to fully understand the role of Hellps in these processes and to develop effective treatments.
Protein Name: Helicase, Lymphoid Specific
Functions: Plays an essential role in normal development and survival. Involved in regulation of the expansion or survival of lymphoid cells. Required for de novo or maintenance DNA methylation. May control silencing of the imprinted CDKN1C gene through DNA methylation. May play a role in formation and organization of heterochromatin, implying a functional role in the regulation of transcription and mitosis (By similarity)
More Common Targets
HELQ | HELT | HELZ | HELZ2 | Heme Oxygenase (HO) | HEMGN | HEMK1 | Hemoglobin A-2 (HbA-2) | Hemoglobulin A (HbA) | HENMT1 | HEPACAM | HEPACAM2 | HEPH | HEPHL1 | HEPN1 | HER (erbB) | HERC1 | HERC2 | HERC2P10 | HERC2P2 | HERC2P3 | HERC2P4 | HERC2P5 | HERC2P7 | HERC2P8 | HERC2P9 | HERC3 | HERC4 | HERC5 | HERC6 | HERPUD1 | HERPUD2 | HES1 | HES2 | HES3 | HES4 | HES5 | HES6 | HES7 | HESX1 | Heterogeneous nuclear ribonucleoprotein complex | HEXA | HEXA-AS1 | HEXB | HEXD | HEXIM1 | HEXIM2 | Hexokinase | HEY1 | HEY2 | HEY2-AS1 | HEYL | HFE | HFM1 | HGC6.3 | HGD | HGF | HGFAC | HGH1 | HGS | HGSNAT | HHAT | HHATL | HHEX | HHIP | HHIP-AS1 | HHIPL1 | HHIPL2 | HHLA1 | HHLA2 | HHLA3 | HIBADH | HIBCH | HIC1 | HIC2 | HID1 | HID1-AS1 | HIF1A | HIF1A-AS1 | HIF1A-AS2 | HIF1A-AS3 | HIF1AN | HIF3A | HIGD1A | HIGD1AP1 | HIGD1AP10 | HIGD1B | HIGD1C | HIGD2A | HIGD2B | High affinity cAMP-specif | High Affinity Immunoglobulin Epsilon Fc Receptor | HIKESHI | HILPDA | HILPDA-AS1 | HINFP | HINT1 | HINT1P1 | HINT2 | HINT3